Showing results (41-50 of 17,407) with videos related to
Sort By:
Pageof 1,741
Bioorganic & Medicinal Chemistry|August 18, 2009
Synthesis and pharmacological evaluation of 6-naltrexamine analogs for alcohol cessationSenait Ghirmai, Marc R Azar, John R CashmanBiochemical Pharmacology|February 6, 2004
Nicotine-related alkaloids and metabolites as inhibitors of human cytochrome P-450 2A6Travis T Denton, Xiaodong Zhang, John R CashmanJournal of Medicinal Chemistry|January 7, 2005
5-substituted, 6-substituted, and unsubstituted 3-heteroaromatic pyridine analogues of nicotine as selective inhibitors of cytochrome P-450 2A6Travis T Denton, Xiaodong Zhang, John R CashmanJournal of Medicinal Chemistry|December 31, 2011
Nonquaternary reactivators for organophosphate-inhibited cholinesterasesJarosław Kalisiak, Erik C Ralph, John R CashmanJournal of Alzheimer'S Disease : JAD|December 31, 2011
Genomic and nongenomic signaling induced by 1α,25(OH)2-vitamin D3 promotes the recovery of amyloid-β phagocytosis by Alzheimer's disease macrophagesMathew T Mizwicki, Danusa Menegaz, Jun Zhang, et al.Bioorganic & Medicinal Chemistry|November 19, 2008
Stereoselective inhibition of serotonin re-uptake and phosphodiesterase by dual inhibitors as potential agents for depressionJohn R Cashman, Troy Voelker, Robert Johnson, et al.Journal of Medicinal Chemistry|June 26, 2026
Antibody-Assisted Protection from Paraoxon and Nerve Agent Model CompoundsCharles M Thompson, Jorge Gomez-Galeno, John R CashmanJournal of Biochemical and Molecular Toxicology|August 15, 2013
Preclinical studies of noncharged oxime reactivators for organophosphate exposureKarl J Okolotowicz, Mary Dwyer, Emily Smith, et al.Tissue Engineering. Part C, Methods|October 22, 2020
Role of Curcuminoids and Tricalcium Phosphate Ceramic in Rat Spinal FusionDaniel A Ryan, Jiongjia Cheng, Koichi Masuda, et al.BMC Neuroscience|December 19, 2008
Immune defects in Alzheimer's disease: new medications developmentJohn R Cashman, Senait Ghirmai, Kenneth J Abel, et al.Pageof 1,741